[ Price : $8.95]
Watson Laboratories recalls two lots of hydrocodone bitartrate and acetaminopen tablets, USP 10 mg/500 mg due to a possibility tha...[ Price : $8.95]
Astex Pharmaceuticals discontinues developing amuvatinib (MP-470), a multi-targeted tyrosine kinase inhibitor being evaluated for ...[ Price : $8.95]
FDA tells ViroPharma and Halozyme Therapeutics to amend their study protocol to resume clinical studies involving a subcutaneous a...[ Price : $8.95]
An unnamed generic drug company files a Paragraph 4 ANDA seeking approval to market a copy of Pfizers Oxecta (oxycodone HCl) table...[ Price : $8.95]
FDA grants final approval to Mylan Pharmaceuticals for its ANDA for valsartan and hydrochlorothiazide tablets USP for treating hyp...[ Price : $8.95]
FDA clears a Smiths Medical 510(k) application for the Portex CorrectInject Safety System for administering neuraxial medication.[ Price : $8.95]
CDERs Office of Generic Drugs releases a draft policy outlining when the Centers Good Laboratory Practice/Bioequivalence Branch sh...[ Price : $8.95]
CDRH director Jeff Shuren says medical device review performance has been showing encouraging improvement since he took over the h...